Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.
Ichikawa
Wataru
W
Araki
Kazuhiro
K
Fujita
Ken-ichi
K
Yamamoto
Wataru
W
Endo
Hisashi
H
Nagashima
Fumio
F
Tanaka
Ryuhei
R
Miya
Toshimichi
T
Kodama
Keiji
K
Sunakawa
Yu
Y
Narabayashi
Masaru
M
Ando
Yuichi
Y
Akiyama
Yuko
Y
Kawara
Kaori
K
Sasaki
Yasutsuna
Y
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects*; D019540:Area Under Curve; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D005838:Genotype; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D000077146:Irinotecan; D009503:Neutropenia / Q000139:chemically induced* / Q000235:genetics; D000099148:UGT1A1 Enzyme
D000972:Antineoplastic Agents, Phytogenic; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme